Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070340 · ClinicalTrials.gov registry record · NA
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT03070340: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03070340 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070340, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the diagnostic accuracy of breast magnetic resonance imaging (MRI) and contrast enhanced digital mammography (CEDM) in assessing the residual disease extent in patients who have completed neoadjuvant therapy (NAT).
Primary Outcome
To compare the diagnostic accuracy of enhancement on MRI and CEDM in evaluating residual disease extent in women who have completed NAT prior to surgical excision
Interventions
- DIAGNOSTIC_TEST Breast Magnetic Resonance Imaging (MRI)
- DIAGNOSTIC_TEST Contrast Enhanced Mammography (CEDM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2023-11-17 |
| Phase | NA |
What the finished NCT03070340 record still lists
NCT03070340 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Breast Magnetic Resonance Imaging (MRI) is the first listed.
NCT03070340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03070340 about?
NCT03070340 is a clinical study titled "Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery". The purpose of this study is to compare the diagnostic accuracy of breast magnetic resonance imaging (MRI) and contrast enhanced digital mammography (CEDM) in assessing the residual disease extent in patients who have completed neoadjuvant therapy (NAT).
What is the current status of trial NCT03070340?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2017-02-28. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT03070340?
The interventions under investigation include: Breast Magnetic Resonance Imaging (MRI) (DIAGNOSTIC_TEST), Contrast Enhanced Mammography (CEDM) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03070340?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03070340's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI